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Abstract
Background: Patients with a history of mild TBI (post-mTBI-patients) have an unexplained increase in long-term
mortality which might be related to central autonomic dysregulation (CAD). We investigated whether standardized
baroreflex-loading, induced by a Valsalva maneuver (VM), unveils CAD in otherwise healthy post-mTBI-patients.
Methods: In 29 healthy persons (31.3 ± 12.2 years; 9 women) and 25 post-mTBI-patients (35.0 ± 13.2 years, 7 women,
4–98 months post-injury), we monitored respiration (RESP), RR-intervals (RRI) and systolic blood pressure (BP) at rest and
during three VMs. At rest, we calculated parameters of total autonomic modulation [RRI-coefficient-of-variation (CV),
RRI-standard-deviation (RRI-SD), RRI-total-powers], of sympathetic [RRI-low-frequency-powers (LF), BP-LF-powers] and
parasympathetic modulation [square-root-of-mean-squared-differences-of-successive-RRIs (RMSSD), RRI-high-frequency-
powers (HF)], the index of sympatho-vagal balance (RRI LF/HF-ratios), and baroreflex sensitivity (BRS). We calculated
Valsalva-ratios (VR) and times from lowest to highest RRIs after strain (VR-time) as indices of parasympathetic activation,
intervals from highest systolic BP-values after strain-release to the time when systolic BP had fallen by 90 % of the
differences between peak-phase-IV-BP and baseline-BP (90 %-BP-normalization-times), and velocities of BP-normalization
(90 %-BP-normalization-velocities) as indices of sympathetic withdrawal.
We compared patient- and control-parameters before and during VM (Mann-Whitney-U-tests or t-tests; significance:
P < 0.05).
Results: At rest, RRI-CVs, RRI-SDs, RRI-total-powers, RRI-LF-powers, BP-LF-powers, RRI-RMSSDs, RRI-HF-powers,
and BRS were lower in patients than controls. During VMs, 90 %-BP-normalization-times were longer, and 90 %-
BP-normalization-velocities were lower in patients than controls (P < 0.05).
Conclusions: Reduced autonomic modulation at rest and delayed BP-decrease after VM-induced baroreflex-
loading indicate subtle CAD with altered baroreflex adjustment to challenge. More severe autonomic challenge
might trigger more prominent cardiovascular dysregulation and thus contribute to increased mortality risk in
post-mTBI-patients.
Keywords: Mild traumatic brain injury, Central autonomic network, Valsalva maneuver, Blood pressure overshoot,
Sympathetic dysregulation, Baroreflex dysfunction
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Background
Traumatic brain injuries (TBIs) are among the leading
causes of mortality and disability [1–3]. In the United
States, approximately 1.6–3.8 million persons experience
a TBI each year [4, 5].
While short-and long-term sequelae are very likely
more frequent and intense in patients with a history of
moderate or severe TBI than in patients with a history
of mild TBI [6, 7], mild TBIs are probably 10 times more
frequent than are moderate or severe TBIs [8]. While
most patients seem to recover within days or weeks after
the mild trauma [9–12], there is increasing evidence of
persistent cognitive, psychological, physical and social
dysfunction, even after mild TBI [6, 12–15].
In prospective studies of patients with a history of
mild TBI, Sung et al. recently showed that depression
persists in women for at least 18 months after the
trauma [14]. The authors also observed an association
between enduring emotional dysfunction [14], lowered
levels of insulin-like growth factor [15] and reduced
autonomic heart rate modulation after mild TBI. They
concluded that altered cardiac autonomic modulation
may predict and contribute to enduring emotional disor-
ders after mild TBI [14, 15].
Autonomic dysfunction might even contribute to the
long-term increase of mortality rates observed in patients
with a history of mild TBI [16–20]. Black and Graham
found unremarkable brain autopsies in patients who died
unexpectedly but had a history of mild TBI (mTBI) [20].
The authors suggested that dysfunction of central auto-
nomic control might contribute to unexpected fatalities
occurring even years after a mTBI [20].
In patients with a history of mTBI (post-mTBI-patients)
but without persistent neurological deficits and without
any clinically overt autonomic dysfunction, we found an
overall decrease in autonomic cardiovascular modulation
at rest with a shift towards more sympathetic and less
parasympathetic cardiovascular control, and a decrease in
baroreflex sensitivity (BRS) [21]. Upon active standing-up,
the baroreflex dysfunction became more evident and re-
sulted in less sympathetic activation and less parasympa-
thetic withdrawal than in our healthy control persons [21].
Based on our findings of reduced BRS at rest and subtle
impairment of cardiovascular adjustment to baroreflex-
unloading upon standing-up, we assume that compromised
central BRS modulation may contribute to autonomic car-
diovascular dysregulation which in turn might contribute
to the increased risk of unexplained fatalities in post-mTBI-
patients. Baroreflex mediated changes in sympathetic and
parasympathetic activity are induced by impulses that
travel via the nucleus tractus solitarii (NTS) towards
rostral central autonomic network (CAN) areas [22].
These CAN areas include, e.g., magnocellular neurons
of the supraoptic and paraventricular nuclei, posterior
hypothalamus, paraventricular and dorsomedial hypo-
thalamic nuclei, preoptic-anterior hypothalamic region,
the periaqueductal gray, the central nucleus of the
amygdala, and the insular cortex [22].
To further test our hypothesis that post-mTBI-patients
have a subtle dysfunction of central baroreflex structures
that adjust efferent baroreflex responses, we evaluated in
this study whether there is a generalized baroreflex dys-
regulation in post-mTBI-patients, i.e. whether baroreflex
responses are not only altered in response to acute
baroreceptor-unloading but also in response to an acute
increase in blood pressure (BP) requiring parasympa-
thetic activation and sympathetic withdrawal.
The Valsalva maneuver (VM) is suited to increase BP
acutely and non-pharmacologically, and to evaluate baro-
reflex mediated parasympathetic activation as well as sym-
pathetic withdrawal [22–26]: HR increases during the
expiratory strain of a VM, while BP rises to an overshoot
after strain-release due to still enduring sympathetic activ-
ity [22–25]. The BP-overshoot after strain-release activates
the baroreflex and triggers parasympathetic activation
with HR-slowing and sympathetic withdrawal with subse-
quent BP decrease to baseline value [22–26].
In this study, we therefore tested cardiovascular auto-
nomic responses to a VM in patients with a history of
mTBI (post-mTBI-patients) but without clinical signs of
autonomic dysfunction.
Methods
In 25 patients (7 women, 18 men, mean age 35.0 years;
standard deviation (SD) 13.2 years) who had experienced
a mTBI 4 to 98 months prior to examination but had no
clinically overt autonomic or other neurological, physical
or psychological dysfunction at the time of our autonomic
evaluation, we studied HR, BP and autonomic responses
to the VM. The interval between autonomic testing and
the initial TBI was on average 34 ± 29 months.
Patients were asked to participate in the assessment
of autonomic function after we had retrospectively
evaluated their medical records, physical and neuro-
logical status and TBI severity at the time of the initial
trauma.
The initial diagnosis of mild TBI was established by a
neurologist or neurosurgeon according to WHO oper-
ational criteria including 1) one or more of the follow-
ing: confusion or disorientation, loss of consciousness
for 30 min or less, post-traumatic amnesia for less than
24 h, and/or other transient neurological abnormalities
such as focal signs, seizure, and intracranial lesion not
requiring surgery; 2) Glasgow Coma Scale (GCS) scores
of 13-15 after 30 min post-injury or later upon presenta-
tion of health care [27].
We only included patients if they met the above cri-
teria of mild TBI, and if conventional cranial computed
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tomography (CCT) or magnetic resonance imaging (MRI)
showed no abnormality at the time of the initial TBI.
We excluded patients from the study in whom the TBI
had occurred due to drugs, alcohol, or medications, to
assure that any signs of autonomic dysfunction cannot
be related to drugs, medication or other diseases affect-
ing the autonomic nervous system. For the same reason,
we also excluded persons with a history of diseases pos-
sibly affecting autonomic regulation such as diabetes,
cardiac arrhythmias, ischemic heart disease or chronic
heart failure, and patients on medication affecting auto-
nomic regulation, e.g., antihypertensive drugs.
Findings in patients were compared to those of 29
age- and sex-matched healthy volunteers (9 women, 20
men, mean age 31.2 ± 12.2 years).
The Institutional Review Board (IRB) of New York
University and the ethics committee of the University of
Erlangen-Nuremberg, Germany, had approved the study.
Written informed consent had been obtained from all
participants according to the declaration of Helsinki. All
patients reported in this manuscript were recruited at
the University of Erlangen-Nuremberg, Germany.
Participants were tested between 9 a.m. and 2 p.m. in
a reclining armchair, in a quiet room with 24 °C ambient
temperature and stable humidity. Before testing, a rest-
ing period of at least 40 min was used to familiarize
participants with our equipment and testing procedures,
and to assure cardiovascular resting stability.
Using a 3-lead electrocardiogram (ECG), we continu-
ously monitored electrocardiographic RR-intervals (RRI).
Systolic and diastolic beat-to-beat BPs (BPsys, BPdia)
were recorded continuously at the left hand, using finger
pulse photoplethysmography (Portapress; TPD BMI) [25].
In addition, we recorded respiratory frequency (RESP)
using a piezoelectric respiratory belt attached to the lower
thorax at the point of maximal respiratory excursion [25].
ECG, BP, and respiratory data were continuously sam-
pled, digitized and displayed on a personal computer
and a custom designed data acquisition and analysis sys-
tem (SUEmpathy™, SUESS Medizin-Technik GmbH, Aue,
Germany) and stored for off-line analysis.
Cardiovascular autonomic modulation was tested at
rest and in response to three reproducible VMs.
To avoid any over-interpretation of potentially abnor-
mal results, we analyzed and interpreted that VM with
the values that reflected the least abnormal of the three
responses.
Assessment of time domain parameters of autonomic
modulation at rest
From 1-min recordings at rest, we calculated mean values
and SDs of all bio-signals. To assess HR variability at rest,
we determined the SD and coefficient of variation (CV) of
RRIs, both reflecting sympathetic and parasympathetic
HR modulation [25, 28], and the square root of mean
squared differences of successive RRIs (RMSSD) reflect-
ing parasympathetic influences on HR or RRI variability
[25, 28].
Analysis of spectral powers of autonomic HR- and
BP-modulation at rest by Trigonometric Regressive
Spectral Analysis (TRS)
HR- or RRI- and BP-values show slow underlying fluctu-
ations that are largely mediated by undulating activity of
the autonomic nervous system [25]. Pharmacologic sym-
pathetic or parasympathetic blockade has shown that
HR- or RRI- oscillations in the so called low frequency
(LF) range from 0.04 Hz – 0.15 Hz at rest are related to
sympathetic activity and - to an undetermined degree -
also to parasympathetic activity, while LF-oscillations of
BP are related to sympathetic outflow only [25, 28].
Moreover, HR- or RRI-oscillations in the so called high
frequency (HF) range from 0.15 Hz – 0.5 Hz are associ-
ated with respiratory sinus arrhythmia and reflect para-
sympathetic activity [25, 28], while HF-oscillations of
BP-values are primarily a mechanical consequence of
respiration-induced fluctuations in venous return and
cardiac output [21, 25, 28].
For spectral analysis of slow sympathetically and para-
sympathetically mediated RRI- and BP-oscillations, we
used trigonometric regressive spectral analysis (TRS) of
30 s epochs [21, 29–31]. Spectral analysis algorithms
ideally require stationarity of the bio-signal during the
epoch of interest [25, 28, 32, 33], a condition that does
not exist in biology in strict terms [33, 34] and is more-
over not compatible with most algorithms’ requirement
of rather long bio-signal time-series recordings [25, 28,
33]. In contrast, the TRS-analysis is suited to evaluate
changes in oscillations of bio-signal recordings as short
as 25–30 s [29, 30, 35]. The TRS-algorithm thus pro-
vides a compromise between the requirement of bio-
signal stationarity, the need to assess brief changes in
autonomic modulation, and the prerequisite of a bio-
signal recording that is still long enough to quantify the
slowest of the oscillations of interest [25, 28]. Basically,
the TRS-analysis does not depend on the length of the
recorded bio-signal time-series but detects physiological
signal oscillations within the duration of a sinusoid oscil-
lation of interest [29, 30]. For the estimation of auto-
nomic influences on HR or BP, the slowest sine-waves of
interest are in the LF-band, at 0.04 Hz, with a wave-
length of 25 s. Thus, the longest recording required for
the quantitative analysis of autonomic signal modulation
in the LF-band does not exceed 25 s [30] (For further
methodological details regarding the TRS-analysis see
[21, 29–31]).
We identified peaks of oscillations in the LF- and HF-
ranges of RRI-, and BP-modulation [25, 28].
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The magnitude of LF- and HF-oscillations was deter-
mined as integral under the power spectral density
curves of RRI (ms2/Hz) and BP (mmHg2/Hz) for the two
frequency bands, and was expressed as LF- and HF-
powers of RRI (ms2) and BP (mmHg2) [21, 25, 28].
To assess differences in the overall autonomic modula-
tion between the patients and healthy participants, we
calculated the sum of LF- and HF-powers as approxima-
tion of the total power (TP) of RRI-oscillations and
index of overall autonomic cardiac modulation [25, 28].
To determine differences between groups in sympathetic
and parasympathetic cardiac modulation, we calculated
the ratio between RRI-oscillations in the LF- and HF-
ranges as a marker of sympathetic-to-parasympathetic
balance [21, 25, 28, 36].
To determine baroreflex sensitivity (BRS), the TRS-
software selected pairs of LF- and HF-oscillations of
BPsys and RRI with high coherence [37]. Coherence
spans from 0, i.e. no association, to 1, i.e. maximum as-
sociation [10]. High coherence at a specific frequency,
e.g., >0.7, indicates a stable phase relation - and thus
synchronization - between two signals oscillating at this
frequency [10]. Then, the sensitivity of the baroreflex loop
(ms•mmHg-1) was derived as gain value from changes in
RRIs (ms) in relation to changes in BPsys (mmHg) [38].
The four phases of the Valsalva maneuver
The VM tests the afferent, central, and efferent sympa-
thetic and parasympathetic baroreflex pathways [39, 40].
VMs were not performed in patients with retinopathy,
glaucoma, cerebral aneurysms, dissections or increased
intracranial pressure. The VM was standardized by asking
the participants to blow into a mouthpiece connected to
an aneroid manometer and to maintain a pressure of
40 mmHg for 15 s while the above mentioned bio-signals
were continuously recorded [22–25]. The response to the
VM includes four phases (Fig. 1). In normal subjects, the
sudden increase of intra-thoracic pressure results in a
brief rise in BP and in a brief fall of HR (phase I) [22–25].
These changes are mainly the result of mechanical influ-
ences. The ongoing strain (phase II) reduces the venous
cardiac return which results in a reduction of ventricular
dimensions, left ventricular stroke volume and cardiac
output. This triggers reflex tachycardia and vasoconstric-
tion [22–25]. The tachycardia during phase II is induced
by a prominent early component with inhibited cardio-
vagal output and a late component with increased sym-
pathetic output [22–25]. In healthy persons, phase II
consists of an early fall in arterial BP and subsequent
partial recovery. The BP recovery during the late phase
II is a result of the progressive increase in total periph-
eral resistance due to increased sympathetic activity
[22–25, 41]. In phase III, a brief fall of arterial BP after
the release of intrathoracic pressure reflects mechanical
factors [22–25]. The HR shows a reflex increase for
usually 3–4 beats [22–25]. The last phase of the normal
response to the VM is a rebound overshoot of BP due
to the persistent vasoconstriction of the arteriolar bed
and to the increased cardiac output that occurs upon re-
lease of the forced expiration [22–25]. This BP-overshoot
during phase IV activates the baroreflex which results in
cardiovagal activation with reflex-bradycardia and in sym-
pathetic withdrawal with peripheral vasodilatation and
subsequent decrease in BP [22–25].
During and after the VM, we assessed the maximum
of BPsys and BPdia during phases I, II late, and IV, and
the minimum of BPsys and BPdia during phases II early,
and III, as well as the minimum of RRI during phases II
late, and III, and the maximum of RRI during phase IV,
within 30 s after strain release.
As index of parasympathetic activation, we calculated
the Valsalva-ratio (VR) which is defined as the ratio be-
tween the highest HR during and the lowest HR within
the first 30 s after the VM, and the time from the lowest
to the highest RRIs after strain (VR-time) [22–25]. As
index of sympathetic withdrawal, we calculated the inter-
val from the highest BPsys-values after strain-release to
the time when BPsys had fallen by 90 % of the differences
between peak-phase-IV BPsys and baseline BPsys as 90 %-
BP-normalization-time (Fig. 1). Furthermore, we calcu-
lated the velocity of BP-normalization, i.e. the difference
between the peak-phase-IV BPsys and the BPsys at the
moment of the 90 %-BP-normalization-time, divided by
the 90 %-BP-normalization-time, and termed this ratio
90 %-BP-normalization-velocity.
Statistical analysis
We used the Kolmogorov-Smirnov test to test for nor-
mal distribution of data. Normally distributed data were
presented as mean ± SD. A t-test was used to test for sig-
nificant differences in age between patients and healthy
participants. Differences in cardiovascular parameters
between patients and healthy participants were evaluated
by t-tests for unpaired samples in case of normally distri-
buted data and by the non-parametric Mann-Whitney-
U-tests for unpaired samples in case of not normally
distributed data. Similarly, we evaluated whether cardiovas-
cular parameters differed between male and female healthy
participants as well as male and female post-mTBI-patients.
Significance was set at P < 0.05. A commercially available
statistical program (SPSS™, SPSS Inc., Chicago, Ill, USA)
was used for data analysis.
Results
Age did not differ significantly between post-mTBI-
patients (35 ± 13 years) and healthy controls (31 ± 12 years,
P > 0.05).
Hilz et al. BMC Neurology  (2016) 16:61 Page 4 of 12
At rest, BPsys, BPdia, and RESP did not differ signifi-
cantly between post-mTBI-patients and healthy controls
(Table 1), while RRIs at rest were slightly though not
significantly lower in the post-mTBI-patients than in
healthy controls.
At rest, parasympathetically and sympathetically medi-
ated RRI-SD, RRI-CV, and parasympathetically mediated
RMSSD as well as BRS were significantly lower in the
post-mTBI-patients than the healthy participants (Table 1).
At rest, RRI-LF-powers, RRI-HF-powers, RRI-total-
powers, and BPsys-LF-powers also were significantly lower
in the post-mTBI-patients than the healthy participants,
while BPsys-HF-powers and RRI-LF/HF-ratios did not dif-
fer significantly between both groups (Table 1).
At rest, none of the above parameters differed between
healthy men and women or between male and female
post-mTBI-patients.
During the VM, patients and healthy participants had
similar values of RRI, BPsys, and BPdia in phase I, early
phase II, late phase II, phase III, and phase IV, and simi-
lar VRs and VR-times (Table 2).
However, patients had longer 90 %-BP-normalization-
times (16.9 ± 7.1 s vs 12.6 ± 4.9 s; P = 0.01) than had the
controls (Table 2, Fig. 2). Moreover, the 90 %-BP-
normalization-velocity was significantly lower in patients
(3.2 ± 1.5 mmHg/s) than in controls (3.8 ± 1.5 mmHg/s;
P = 0.04; Table 2, Fig. 2).
During the VM, only the maximum RRI-values during
phase IV, i.e. after strain-release, differed between male
and female post-mTBI-patients. Heart rate slowing after
strain-release resulted in smaller RRI-values in the female
than the male patients (979.0 ± 114.3 ms vs. 1156.9 ±
216.4 ms; P = 0.015). Consequently, the VR was lower in
the female than the male patients (1.6 ± 0.2 vs. 1.9 ± 0.3;
P = 0.015), and the VR-time was longer in the female than
the male patients (16.2 ± 4.6 s vs. 12.8 ± 2.8 s; P = 0.03).
Discussion
Similar to our previous findings [21], the current data con-
firm that patients with a history of mTBI have a mild - at
rest clinically silent - reduction in the autonomic modula-
tion of HR and BP. Again, all time- and frequency-domain
parameters of autonomic HR- and BP- modulation were
smaller than in our controls (P < 0.05). However, in the
current study, RRI-LF/HF-ratios of patients and controls
were similar, suggesting that there was no shift towards a
predominance of sympathetic over parasympathetic modu-
lation as we had seen it in the post-mTBI-patients of our
previous, orthostatic challenge study [21]. Yet, the barore-
flex sensitivity at rest was similarly decreased in the patients
Fig. 1 Time-series of systolic blood pressure (BPsys) and heart rate (HR) during the Valsalva maneuver. For a healthy participant and a post-mTBI-
patient, the double-headed arrows indicate the intervals from the highest systolic blood pressure (BPsys) value after strain to the time when BPsys
had fallen by 90 % of the difference between peak-phase-IV BPsys and baseline BPsys, i.e. the 90 %-blood-pressure-normalization-time. “Start” and
“stop” refer to the beginning and release of expiratory strain during the Valsalva maneuver
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Table 2 Bio-signals and autonomic parameters during Valsalva maneuver in 25 post-mTBI-patients and 29 healthy controls
Parameters Healthy controls Post-mTBI-patients Controls vs. patients
RRI phase II late [ms] 643.5 ± 115.4 633.40 ± 85.0 P = 0.86
RRI phase III [ms] 628.0 ± 108.5 613.3 ± 78.3 P = 0.58
RRI phase IV [ms] 1148.0 ± 160.8 1106.24 ± 208.4 P = 0.41
Valsalva-ratio 1.9 ± 0.4 1.8 ± 0.4 P = 0.46
Valsalva-ratio-time [s] 13.9 ± 3.8 13.7 ± 3.7 P = 0.83
BPsys phase I [mmHg] 166.6 ± 20.6 161.2 ± 13.7 P = 0.27
BPsys phase II early [mmHg] 110.0 ± 19.5 105.7 ± 19.8 P = 0.44
BPsys phase II late [mmHg] 141.0 ± 23.8 134.0 ± 24.2 P = 0.29
BPsys phase III [mmHg] 107.5 ± 17.5 101.1 ± 20.9 P = 0.25
BPsys phase IV [mmHg] 177.7 ± 26.6 177.4 ± 21.7 P = 0.76
BPdia phase I [mmHg] 88.8 ± 14.3 86.3 ± 11.2 P = 0.49
BPdia phase II early [mmHg] 66.8 ± 10.7 67.2 ± 12.44 P = 0.90
BPdia phase II late [mmHg] 89.8 ± 13.9 87.0 ± 15.7 P = 0.31
BPdia phase III [mmHg] 64.4 ± 9.3 63.9 ± 11.3 P = 0.88
BPdia phase IV [mmHg] 85.8 ± 10.5 86.4 ± 10.4 P = 0.84
90 %-BP-normalization-time [s] 12.6 ± 4.9 16.9 ± 7.1 P = 0.01
90 %-BP-normalization-velocity [mmHg/s] 3.8 ± 1.5 3.2 ± 1.5 P = 0.04
Mean values ± standard deviation of maximum or minimum values of RR-intervals, systolic and diastolic blood pressure during the different phases of the Valsalva
maneuver, as well as the Valsalva-ratios, Valsalva-ratio-times, 90 %-blood-pressure-normalization-times and 90 %-blood-pressure-normalization-velocities, in 25
patients with a history of mild TBI and 29 healthy controls. Significant differences (p < 0.05) between patients with a history of mTBI (post-mTBI-patients) and
healthy participants are in italic and bold
mTBI mild traumatic brain injury, RRI RR-interval, BPsys systolic blood pressure, BPdia diastolic blood pressure, BP blood pressure
Table 1 Bio-signals and autonomic parameters at rest in 25 post-mTBI-patients and 29 healthy controls
Parameters at rest Healthy controls Post-mTBI-patients Controls vs. patients
RRI [ms] 908.4 ± 132.9 868.7 ± 138.0 P = 0.17
BPsys [mmHg] 130.6 ± 17.0 127.5 ± 16.6 P = 0.51
BPdia [mmHg] 66.6 ± 8.6 66.1 ± 7.6 P = 0.82
Respiration [min-1] 13.1 ± 3.8 14.8 ± 3.6 P = 0.101
RRI-SD [ms] 59.0 ± 29.3 38.6 ± 18.6 P = 0.005
RRI-CV [ms] 6.6 ± 3.3 4.5 ± 2.1 P = 0.02
RRI-RMSSD [ms] 48.4 ± 27.8 31.2 ± 18.3 P = 0.02
BRS [ms/mmHg] 12.4 ± 5.9 9.2 ± 4.0 P = 0.043
RRI-LF-powers [ms2] 2417.7 ± 2441.6 953.5 ± 867.8 P = 0.009
RRI-HF-powers [ms2] 1188.7 ± 1374.6 567.4 ± 581.9 P = 0.032
RRI-total-powers [ms2] 3606.4 ± 3544.7 1520.9 ± 1300.25 P = 0.009
RRI-LF/HF-ratio 3.0 ± 2.1 3.6 ± 3.1 P = 0.42
BPsys-LF-powers [mmHg2] 12.5 ± 3.9 9.7 ± 4.0 P = 0.014
BPsys-HF-powers [mmHg2] 5.1 ± 2.2 4.6 ± 3.0 P = 0.25
Mean values ± standard deviation of RR-intervals, systolic and diastolic blood pressures, respiratory frequency, time domain parameters of RRI-variability, and
frequency domain parameters reflecting powers of autonomic modulation of RR-intervals and systolic blood pressures in 25 patients with a history of mild TBI
and 29 healthy controls at rest. Significant differences (p < 0.05) between patients with a history of mTBI (post-mTBI-patients) and healthy participants are
indicated in italic and bold
mTBI mild traumatic brain injury, RRI RR-interval, BPsys systolic blood pressure, BPdia diastolic blood pressure, SD standard deviation, CV coefficient of variation,
RMSSD root mean square of the successive differences, BRS baroreflex sensitivity, LF low frequency, HF high frequency
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of the current study as it was in the post-mTBI-patients of
the preceding baroreflex-unloading study [21].
Again, the impairment of autonomic modulation seemed
to be minor as it did not affect HR- and BP-responses
during the various VM-phases. In fact, HR-, BPsys-, and
BPdia-values did not differ between patients and controls
during the four VM-phases. Not even the Valsalva-ratio,
which is commonly determined to assess the cardiovagal
baroreflex buffer capacity in response to the BP-overshoot
after strain-release [25, 42, 43], nor the times from the
lowest to the highest RRIs after strain, the VR-times,
differed between our patients and healthy participants.
Only the 90 %-BP-normalization-times and the 90 %-
BP-normalization-velocities which we used to measure
BP readjustment from maximal BP-values after strain-
release to baseline BP-values, and which reflected the
quality and velocity of baroreflex mediated sympathetic
withdrawal in response to baroreceptor-loading, showed
a subtle dysfunction of the central reflex modulation.
This dysfunction seemed to be more prominent in female
than in male post-mTBI-patents. In the female patients,
heart rate slowing after strain-release was significantly
smaller and resulted in smaller RRIs during phase IV of the
VM, with subsequently smaller Valsalva ratios and longer
VR-times than in the male patients. The findings show that
the baroreflex-mediated parasympathetic buffer capacity of
heart rate is smaller in female than in male post-mTBI-
patients. We cannot rule out that these differences are to
some extent due to a slight physiological gender difference
in parasympathetic cardiovascular buffering after brief
blood pressure increases, as described in previous studies
[44, 45]. However, the data might also indicate that persis-
tent autonomic dysfunction is more prominent in women
than men after mTBI. The gender related differences show
some conformity with recently reported differences
between male and female patients regarding autonomic
and emotional sequelae of mTBI. Sung et al. found that re-
duced heart rate variability after mTBI correlated with
long-lasting and deteriorating depression in female patients
only [14]. Thus, our findings of more severely altered baro-
reflex function in female than male patients might suggest
that women are more prone to persistent autonomic dys-
function after mTBI than are male patients.
Various mechanisms might account for autonomic car-
diovascular changes in patients with a history of mild TBI,
including the psychological impact of the initial mild TBI,
post-traumatic anxiety or depression [12], altered cerebro-
vascular regulation [13], and particularly prolonged rest
after the trauma [13]. Many studies show that physical ex-
ercise and endurance training augment cardiovascular
autonomic modulation [46–48]; while sedentary life-style
and physical inactivity attenuate cardiac autonomic regu-
lation and baroreflex sensitivity [49, 50].
Consequently, the autonomic cardiovascular changes
of our patients at rest and after release of the VM-strain,
might be ascribed to physical deconditioning after the
Fig. 2 The 90 %-blood-pressure-normalization-times and 90 %-blood-pressure-normalization-velocities in healthy controls and post-mTBI-patients.
The 90 % normalization-times of systolic blood pressure (BPsys), i.e. the intervals from the highest BPsys-values after VM strain-release to the times
when BPsys had fallen by 90 % of the differences between peak-phase-IV BPsys and baseline BPsys, were longer in the 25 patients with a history
of mild TBI than in the healthy participants. The 90 %-blood-pressure-normalization-velocities, i.e. the differences between peak-phase-IV BPsys
and BPsys at the moment of the 90 %-BP-normalization-time, divided by the 90 %-BP-normalization-times, were lower in the post-mTBI-patients
than in the healthy participants. Data are presented as box plots. The line in the middle of the box represents the median (50th percentile), the
top of the box represents the upper quartile (75th percentile), the bottom of the box represents the lower quartile (25th percentile), and the end
of the whiskers represent the highest and lowest values that are not extreme values or outliers. Grey boxes illustrate results in healthy participants;
white boxes with vertical lines illustrate results in the 25 patients with a history of mild TBI
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injury. In fact, various symptoms, including headache,
dizziness, fatigue, depression, or cognitive difficulties
may persist for an extended period of time in patients
even after mild TBI [13, 51]. However, most patients re-
cover swiftly after mild TBI [9, 11, 52, 53]. Similarly, our
patients also seemed to have fully recovered from their
mild TBI, and none of them had signs or symptoms of
clinically overt autonomic dysfunction, psychological or
physical impairment, or reported any change in physical
activity compared to the level of activity prior to the
TBI. Moreover, we tested the patients many months after
their TBI; two patients were tested 4 and 5 months after
the trauma, four patients were tested after 6 to 12 months,
and the remaining 19 patients underwent autonomic
testing more than 12 months after the injury. Thus, effects
of physical inactivity - which may have occurred during
the first months after the TBI – might not explain the
decreased autonomic modulation at rest and the delayed
withdrawal of baroreflex-mediated sympathetic BP modu-
lation. Ferretti et al. [49] showed that resumption of
normal physical activity rapidly reverses attenuating
effects of prolonged physical inactivity on autonomic
modulation. The authors reported that the decrease in
cardiovascular autonomic modulation and BRS induced
by 3 months of head-down bed-rest recovered within five
days after return to normal activity [49].
In summary, we cannot fully rule out attenuating
effects of physical inability or other e.g., psychological
impediments, on the cardiovascular autonomic modula-
tion of our patients although these effects seem rather
unlikely. Instead, we assume that the autonomic cardio-
vascular changes at rest and after release of the VM-
strain support our previous conclusion that the initial
trauma may have caused a minute disruption of CAN
pathways even though the trauma was only mild and
caused no cerebral lesions visible on conventional CCT
or MRI [21]. However, more recent neuroimaging tech-
niques such as diffusion tensor weighted MRI demon-
strate microstructural brain lesions even in mild TBI
patients suggesting fiber and thus pathway disruption
[54–60] or even cerebral volume loss [46] that may per-
sist years after the initial trauma [46, 55, 56, 61].
As mentioned above, efferent responses to loading
or unloading of baroreceptors are modulated by many
CAN structures distributed throughout the neuraxis
[22, 62], e.g., the magnocellular neurons of the supra-
optic and paraventricular nuclei, posterior hypotha-
lamus, paraventricular and dorsomedial hypothalamic
nuclei, preoptic-anterior hypothalamic region, the
periaqueductal gray, the central nucleus of the amyg-
dala, and the insular cortex [22]. While – the
assumed - minor lesions within this network did not
cause clinically manifest autonomic dysfunction in
any of our patients, abundant studies confirm that
a decrease in the ability to modulate autonomic func-
tion is a risk factor for cardiovascular complications
and increased mortality, e.g., in patients with myocar-
dial infarction [63, 64], congestive heart failure [65],
renal failure [66], acute ischemic or hemorrhagic
stroke [67–70], and diabetes [71–73].
Similarly, the decrease in baroreflex sensitivity, observed
already at rest, also indicates an increased cardiovascular
risk. Reduced baroreflex function, again, has been shown
to correlate with an increased risk of cardiac complications,
poor outcome and increased mortality, in various diseases,
such as arterial hypertension, heart failure, myocardial in-
farction, renal failure, diabetes, ischemic or hemorrhagic
stroke [63, 74–81].
In a two year prospective study of 1011 community-
dwelling 65-year-old persons, Dauphinot and co-workers
showed that reduced BRS was associated with the develop-
ment of arterial hypertension [82]. In a 19-year prospective
study comprising 559 middle-aged persons, Kiviniemi et al.
recently showed that reduced BRS was the most potent
predictor of cardiovascular death [83]. Reduced BRS might
even be a predictor of sudden death [75].
The delayed BP decrease after release of the VM-strain
further suggests an increased risk of cardiovascular dysregu-
lation. Normally, cardiovascular baroreflex responses to re-
ceptor loading or unloading occur almost instantaneously,
usually within one heart beat [26]. Any delay in efferent
reflex responses may trigger cardiovascular instability [26].
Such delayed cardiovascular baroreflex responses have been
reported in various diseases that are associated with an
increased cardiovascular risk [84–90].
In our patients, the subtle autonomic changes did not
cause any clinically overt abnormality. Still, the finding
that our patients needed longer to lower BP after the VM,
suggests that they have a mild dysregulation of sympa-
thetic activity. While maneuvers such as our standardized
VM or active standing-up only pose a mild autonomic
challenge, more pronounced maneuvers might result in
more prominent autonomic dysregulation. Maneuvers
similar to, but more stressful than a standardized VM are
common in daily life, and occur inadvertently, e.g., during
lifting heavy weights or even bowel emptying. We assume
that a more prominent strain might trigger more severe
dysregulation even in patients as ours, with only minor
autonomic dysregulation at rest or during mild challenge.
After acute TBI, sympathetic hyperactivity is rather
common and has been ascribed to, e.g., axonal injury or
hypoxia [91]. In patients with a history of severe TBI, epi-
sodes of sympathetic hyperactivity may persist for years
[92]. Bursts in sympathetic activity may induce secondary
cardiovascular damage including cardiac arrhythmias,
myocardial necrosis, cerebral hemorrhage, and even sud-
den unexplained death [86, 93, 94]. In patients with a his-
tory of only mild TBI, such post-concussion sequelae very
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likely are less frequent and intense than in patients with
a history of moderate or severe TBI [95]. Still, daily life
activities implying pronounced autonomic cardiovascu-
lar challenge might trigger clinically relevant cardiovas-
cular dysfunction even in patients with a history of only
mild TBI.
In summary, our study complements and confirms our
previous findings of altered baroreflex function upon
receptor-unloading [21]. Even patients with a history of
only mild TBI may have a dysfunction of autonomic
modulation at rest and compromised efferent baroreflex
responses upon loading as well as unloading of barore-
ceptors. Under normal conditions, this dysfunction
seems to remain without clinical sequelae. Yet, highly
strenuous circumstances or maneuvers might yield an
autonomic derangement which could contribute to the
increased cardiovascular risk of patients with a history
of mTBI [16–20]. In daily life, activities similar to and
perhaps even more stressful than a Valsalva maneuver,
such as blowing one’s nose or bowel emptying, cannot
be avoided and might trigger autonomic dysregulation.
Therefore, post-mTBI-patients should be tested for car-
diovascular dysregulation upon autonomic challenge,
and then closely monitored in an attempt to mitigate
the risk of cardiovascular events or emotional and psy-
chiatric complications, as shown e.g. by Sung et al. [14].
Limitations of the study
Our data reflect the findings in only a rather small num-
ber of patients and healthy controls. However, we had to
exclude persons from study who were on any medication
possibly affecting autonomic function as well as patients
who had any clinically overt signs of autonomic dysfunc-
tion or any disease afflicting the autonomic nervous sys-
tem. These exclusion criteria assured that we tested only
patients in whom possible findings of autonomic dys-
function could not be ascribed to other causes than the
precedent TBI. Still, a larger number of patients and
controls would have strengthened the study power and
our conclusions.
Another limitation may arise from the wide interval
between the times of our autonomic evaluation and the
initial mTBI. Patients very likely were at different stages
of recovery from mTBI and therefore might have had
variable changes in autonomic function. A narrow time
frame between the initial trauma and the autonomic as-
sessment might better reflect autonomic function in pa-
tients at a more homogenous stage of recovery from
mTBI. Yet, Sung et al. recently showed that even changes
in heart rate variability recorded within the first week after
mTBI are associated with long-term emotional sequelae,
such as depression in woman occurring as late as 1.5 years
after the mTBI [14]. Our data from patients with a widely
dispersed recovery time since their mTBI provide evidence
that autonomic cardiovascular dysfunction persists after
mTBI not only for several months but for more than 8
years. These findings are in conformity with the studies
by Teasdale’s group showing a long-lasting increase in
mortality rates, for up to at least 15 years, even after
mTBI [18, 19, 96].
Still, the autonomic evaluation of several adequately
large patient groups tested after different though narrow
intervals since the initial mTBI might show whether and
how autonomic dysfunction develops or recovers after
mTBI.
Moreover, we cannot rule out that patients who have
suffered a mild TBI might tend to have a more stressful
life which may increase sympathetic cardiovascular
activity. However, in conjunction with our previous stu-
dies, our finding of delayed normalization of increased
sympathetic activity after the VM challenge suggests a
tendency towards increased cardiovascular risk due to
an altered sympathetic-parasympathetic balance.
While we cannot prove that the subtle autonomic dys-
function found in our patients causes the increased risk
of long-term mortality that has been described in epi-
demiological studies [16–18, 20], autonomic dysfunction
is known to increase the risk of long-term mortality
[74–76, 79, 97–99].
Conclusions
In summary, we conclude that our findings of subtle auto-
nomic and particularly baroreflex dysfunction support our
hypothesis that autonomic dysregulation may contribute
to cardiovascular imbalance, which in turn increases the
risk of cardiovascular events and ultimately death, even
years after the initial TBI.
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